Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02023463
What this trial is testing

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
Thomas Jefferson University 25
Not applicableStudy completedNCT02163317
What this trial is testing

Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00058084
What this trial is testing

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT01656304
What this trial is testing

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Barbara Ann Karmanos Cancer Institute 16
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Not applicableStudy completedNCT02339948
What this trial is testing

Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
GenesisCare USA 279
Testing effectiveness (Phase 2)Study completedNCT00078910
What this trial is testing

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 130
Testing effectiveness (Phase 2)Study completedNCT00003323
What this trial is testing

Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerSexual Dysfunction and Infertility
Alliance for Clinical Trials in Oncology 101
Testing effectiveness (Phase 2)Ended earlyNCT01093183
What this trial is testing

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Nebraska 25
Testing effectiveness (Phase 2)Study completedNCT00438464
What this trial is testing

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate Cancer
National Cancer Institute (NCI) 204
Large-scale testing (Phase 3)Study completedNCT01546987
What this trial is testing

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 239
Testing effectiveness (Phase 2)Study completedNCT00003614
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT04033432
What this trial is testing

SEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents+7 more
Northwestern University 14
Large-scale testing (Phase 3)UnknownNCT00376792
What this trial is testing

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Scandinavian Prostate Cancer Group 396
Testing effectiveness (Phase 2)Looking for participantsNCT04734730
What this trial is testing

Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT00736645
What this trial is testing

Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 55
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00337077
What this trial is testing

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-refractory Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 121
Testing effectiveness (Phase 2)Looking for participantsNCT06067269
What this trial is testing

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Who this might be right for
Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 95
Testing effectiveness (Phase 2)UnknownNCT00003183
What this trial is testing

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Hope Cancer Institute, Inc. 64
Next Page